Open Access

Research progress of berberine mediated photodynamic therapy (Review)

  • Authors:
    • Ya-Wen An
    • Hong-Tao Jin
    • Bo Yuan
    • Jian-Chun Wang
    • Cheng Wang
    • Han-Qing Liu
  • View Affiliations

  • Published online on: March 8, 2021     https://doi.org/10.3892/ol.2021.12620
  • Article Number: 359
  • Copyright: © An et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Berberine (BBR) is a plant secondary metabolite that has been used in photodynamic therapy (PDT) in the last few decades. The present review aimed to discuss the research progress of BBR‑mediated photodynamic actions. The following key words were searched in several databases: ‘Berberine’ combined with ‘photodynamic therapy’, ‘sonodynamic therapy (SDT)’, ‘ultraviolet’, ‘reactive oxygen’ and ‘singlet oxygen’. The results demonstrated that both type I and type II reactions participated in the photodynamic progression of BBR derivatives. In addition, the photochemical characteristics of BBR derivatives were affected by the polarity, pH and O2 content of solvents. DNA binding increases the lifespan of the photoexcited BBR state and generation of singlet oxygen (1O2). The chemical properties of substituents in different positions of the BBR skeleton are pivotal for its photochemical properties, particularly the methylenedioxy group at the C‑2 and C‑3 positions. BBR is a promising agent for mediating both PDT‑ and SDT‑treated diseases, particularly in tumors. However, further studies are required to validate their biological effects. In addition, the molecular mechanisms underlying the antitumor effects of BBR‑PDT remain unclear and warrant further investigation. The structural modification and targeted delivery of BBR have made it possible to broaden its applications; however, experimental verification is required. Overall, BBR acts as a sensitizer for PDT and has promising development prospects.

Introduction

Photodynamic therapy (PDT) has significantly developed in the last 100 years and is a promising therapeutic modality for the treatment of cancer, dermatosis and bacterial infections (13). The main components of PDT include a photosensitizer, molecular oxygen and light irradiation (1). Following light irradiation of the photosensitizer, molecular oxygen can produce reactive oxygen species (ROS), including singlet oxygen (1O2), superoxide radical anion (O2•−), hydrogen peroxide and hydroxyl radicals (OH), to exert various roles in different biological processes, in general, 1O2 is involved in energy transfer and the free radicals are involved in electron transfers (4). The photosensitizer is the most important factor for PDT (2). However, cell specificity and selectivity remain insufficient for most photosensitizers (5). Notably, products from herbal plants, such as hypericin, curcumin, psoralen and berberine (BBR) have been demonstrated to act as photodynamic agents, exhibiting potential for wide applications in PDT (68).

BBR is an important isoquinoline alkaloid isolated from traditional medicines, such as Berberis aristata Sims, Coptis chinensis Franch and Coptis japonica Makino (Fig. 1). Coptis chinensis Franch belongs to the wild plant medicinal materials under secondary protection in China (9). BBR is produced in plants as a secondary metabolite and possesses a range of pharmacological properties (1012). To the best of our knowledge, Philogène et al (13) were the first to demonstrate that BBR generates 1O2, which is considered the main product of photodynamic reactions (2). Wang et al (14) studied the photodynamic activity of BBR on cancer cells in 1986. Our recent studies demonstrated that BBR-mediated PDT and sonodynamic therapy (SDT) significantly inhibit tumor cells in vivo (15,16). As a photosensitizer, BBR possesses several advantages, such as easy production, low cost and various pharmacological effects, including antitumor functions (15). However, BBR also possesses several disadvantages, including toxicity and poor water solubility (16).

The present review focuses on the photodynamic characteristics of BBR and its biological effects via PDT and SDT, as well as its molecular mechanisms, defects and potential strategies to provide novel insights for future development.

Photodynamic characteristics of BBR

BBR is sensitive to light and can react in the presence of changing energy levels, such as several other secondary metabolites, including coralyne, sauguinarine and palmatine (15,17). All plant compounds have specific biological functions, whose effects have been demonstrated to be effective in animal cells, including humans (1723). Philogène et al (13) were the first to report that BBR is an 1O2 generator via 2,5-dimethyl furan (DMF) experiments. DMF is easily oxidized, thus, by measuring its decrease in absorbance at 220 nm, 1O2 generation can be indirectly measured (24). The results of this study demonstrated that the first-order rate constant (k) of 1O2 generation induced by BBR and UV was 2.1×10−4/S1. Arnason et al (25) detected 1,270 nm near-infrared phosphorescence produced by BBR with near UV exposure, where the phosphorescence at 1,270 nm was considered as direct evidence of 1O2 generation. The results of this study demonstrated that the singlet oxygen yield (ΦΔ) of BBR was 0.25 in dichloromethane (CH2Cl2) solution. Since then, a series of studies have demonstrated that both type I and type II reactions are involved in UV light excitation for BBR, the photochemistry is influenced by polarity, oxygen content and pH of solvents, and the DNA-binding and photochemical functional group of BBR (2628).

Types of photodynamic reactions for BBR

There are two types of reactions that are involved in PDT. Type I reactions involve electron transfers and result in the production of free radicals, while type II reactions involve energy transfer and result in the production of 1O2 (4,5). The 1,270 nm near-infrared phosphorescence is considered the characteristic absorption peak of 1O2 and has been used to calculate the ΦΔ in most studies (29,30). The electron paramagnetic resonance (EPR) spin trapping technique is typically used to detect free radical photogeneration and triplet state, with the aid of 5,5-dimethyl-1-pyrroline N-oxide (26). EPR and 2,2,6,6-tetramethyl-4-piperidinol can also be used to detect 1O2 (27).

Both types of reactions are involved in BBR-PDT (Fig. 2). Briefly, following exposure to UV light, BBR is excited (4). There are three ways for the excited-state BBR to return to the ground state: Internal conversion, release of fluorescence and reaching the triplet excited state of BBR (3BBR*) through intersystem crossing (28). 3BBR* produces 1O2 and other oxygen free radicals by energy transfer and electron transfer, under aerobic conditions (28). Both 1O2 and free radicals can react with biomolecules, but 1O2 is more efficient (2). Furthermore, a 1,270 nm phosphorescence can be detected in combination with 1O2 generation (29).

Inbaraj et al (26) reported that BBR in aqueous (D2O) solutions exposed to light does not generate 1O2. However, the ΦΔ in CH2Cl2 was 0.34, which was higher than that detected in the study by Philogène et al (13); in non-polar environments, BBR can generate both 1O2 and radical species, such as O2•−, OH and neutral BBR radicals (BBR). Irradiation (313 nm) to BBR in frozen methanol (MeOH) produced strong triplet signals, while in D2O, no populated triplet state of BBR was observed (13). Brezová (27) et al demonstrated that both 1O2 and O2•− are produced following BBR irradiation in oxygenated dimethyl sulfoxide (DMSO) solvent. In addition, Jantová et al (31) observed the generation of superoxide anion radicals and 1O2 in aerated solutions of BBR upon photoexcitation, and demonstrated that both type I and II mechanisms are involved in the efficient activation of molecular oxygen. Cheng et al (28,32) reported that BBR can be activated by both 266 and 355 nm laser and produce 3BBR*, BBR radical anions and BBR radical cations (BBR•+). Furthermore, fast deprotonation of BBR•+ can produce BBR neutral radicals, suggesting that both type I and type II reactions are activated (28). These results were verified by investigating the interaction mechanisms between BBR and lysozyme (Lys), and the results demonstrated that type I reactions compete with 1O2 (33). Shen and Ji (34) obtained the lowest triplet excitation energy of BBR and elucidated the characteristics of the triplet excited state using the time-dependent density functional theory. The results of this study proved that the direct energy transfer and electron transfer pathways are involved in the generation of 1O2 and O2•−, respectively. Liu and Zhang (35) investigated the UV-induced photo-electrocatalytic degradation of the BBR chloride form and demonstrated that the ROS produced during the reaction were O2•−, OH and sulfate radicals.

Effects of solvents on the photodynamic reaction of BBR

It has been demonstrated that BBR can mediate photodynamic reactions. Several studies have confirmed that the photodynamic reactions of BBR are affected by several factors, such as solvent type, DNA binding and photochemical functional group (28,34,36). The photochemical reactions of BBR are influenced by solvents polarity (26). Inbaraj et al (26) systemically studied the photochemistry of BBR in different solvents. The results of the present study demonstrated that the ΦΔ of BBR was the highest in CH2Cl2 (0.34), followed by toluene (0.044), 1,4-dioxane (0.042) and acetonitrile (MeCN; 0.038), while exposure to light did not generate 1O2 in D2O solutions. The order of the fluorescence quantum yield in different solvents was as follows: 1,4-dioxane (0.071) > zethanol (EtOH, 0.036) > MeCN (0.025) > propylene carbonate (0.007). Taken together, these results suggest that BBR is a weak photosensitizer in water; however, it can produce both 1O2 and radical species in nonpolar environments. Shen and Ji (34) observed the ROS photogeneration of BBR and demonstrated that both the generation of 1O2 and O2•− were highly dependent on solvent polarity. O2•− was only produced in EtOH; however, 1O2 was generated in both EtOH and benzene. Collectively, these results indicate that a much higher ΦΔ is observed in non-polar solvents compared with polar solvents. Görner et al (37) implied that the decrease in BBR ΦΔ upon increasing solvent polarity was due to the dramatical acceleration of its internal conversion and reduction of the triplet rate formation yield. Notably, Cheng et al (28) reported that in laser flash photolysis, BBR exposure to a 266 nm laser in an aqueous solution produces hydrated electrons through a monophotonic process, and the hydrated electrons react with the steady state of BBR to form anion radicals, radical cations and neutral radicals. The quantum yield of photoionization was determined to be 0.03. Notably, Görner et al (36) demonstrated that photoinduced electron ejection does not play a role in oxidation. Generally, BBR is more prone to photochemical reactions in nonpolar solvents than in polar solvents, and the ROS yield is higher in non-polar solvents (28,36,37). In addition, the pH of solvents also affects the reaction (36). Görner et al (36) reported that the quantum yield of BBR-sensitized oxidation in oxygenated alkaline MeOH solution significantly increased with an increase in pH, reaching a yield of 0.4 at pH 13.8.

In addition to solvent polarity, the oxygen content of solvents is also considered to play an important role in the light activation of BBR. Brezová et al (27) demonstrated that upon irradiation, BBR produces both O2•− and 1O2 in DMSO. Furthermore, Hirakawa et al (38) reported that photoexcited BBR causes DNA cleavage under aerobic conditions, but no DNA photodamage was observed under anaerobic conditions. Jantová et al (31) revealed that EPR signals of photoexcited BBR in argon-saturated DMSO solutions are very low, while EPR signals of photoexcited BBR was higher in DMSO saturated by air or oxygen; the addition of SOD substantially decreased the formation of superoxide anion radicals, thus confirming unambiguously the photoinduced electron transfer from the photoexcited BBR to molecular oxygen; and the generation of superoxide anion adducts declined following the addition of superoxide dismutase; the aforementioned set of experiments confirmed the requirement of BBR, O2 and light for effective ROS generation.

Notably, other reactions upon laser irradiation of BBR exist besides photooxidation processes. Cheng et al (28,32,33) studied the photoionization and photoexcitation of BBR in N2- and O2-saturated systems. The results of these studies demonstrated that upon laser excitation at 355 nm, an absorption band ~420 nm and an obvious bleach ~360 nm of BBR was observed in N2-saturated MeCN, and O2 significantly affected the species with 420 nm absorption. In the presence of O2, the decay of 3BBR* in N2-bubbled MeCN was accelerated; the absorption value of bleaching is lower in the O2-saturated system than in the N2-saturated system, which indicates that another transient species may have been formed in addition to 3BBR*, and the total yield of bleaching should include both BBR•+ and 3BBR* in the N2-saturated system (32). Similar phenomena were observed upon 266 nm laser excitation. After the laser pulse, the depletion of ground states of BBR was observed as chartered absorption bleaching at 350 nm and both ionization and excitation contributed to the bleaching of BBR in the N2-saturated system, while in the O2-saturated system, only ionized processes were involved (28). Active radicals of BBR have also been observed, induced by laser oxidized tryptophan (Trp) of Lys via electron transfer progression in O2-free polar solvents; however, in the presence of O2, both electron and energy transfer mechanisms are involved in photooxidation (33). Görner et al (37) studied the photoreduction and ketone-sensitized reduction of alkaloids, including BBR. The results of this study demonstrated that the major photoproducts of alkaloids are dihydroalkaloids and are reverted back to the corresponding alkaloids upon exposure of O2. In addition, it was indicated that Rose Bengal, a photosensitizer, significantly accelerates BBR photooxidation in oxygenated alkaline MeOH solutions, suggesting the importance of Rose Bengal-sensitized 1O2 in the reaction (36,37).

Taken together, these findings demonstrate the complexity of the photochemical reactions of BBR and the important roles of O2. Since 1O2 has proven efficient in destroying biomolecules, more attention should be paid on the balance between photooxidation, photoionization and photoreduction in biological applications.

Interaction between BBR and DNA

DNA is an important molecular target of BBR (39). DNA binding and its effects on the photochemical properties of BBR were recently discovered. Hirakawa et al (38) revealed the mechanism of guanine-specific photooxidation of BBR and demonstrated that BBR easily binds to DNA and forms a strong fluorescent complex, which is necessary for 1O2 generation. In addition, BBR is unable to produce 1O2 in the absence of DNA. Furthermore, the authors discovered switches in 1O2 activity resulting from the DNA microenvironment, and that BBR can bind to DNA by electrostatic forces. This binding significantly enhances the lifespan of its photoexcited state by inhibiting quenching via electrostatic forces (40). The dynamics of 1O2 generation by DNA-binding BBR were assessed and the results demonstrated that 1O2 generation is led by energy transfer from the DNA-binding BBR complex to molecular oxygen (41). The guanine sequence decreased the ΦΔ by deactivating the singlet excited state of BBR, and steric hindrance of DNA decreased the constant rate of 1O2 generation (41).

BBR also induces DNA photodamage (40). Guanine is the most easily oxidized base of DNA (42). Hirakawa et al (38) demonstrated that photoexcited BBR induces piperidine-sensitive calf thymus DNA damage, specifically at almost all guanine residues under aerobic conditions, but barely induces direct DNA strand breaks. Conversely, Jantová et al (31) reported that BBR significantly induces direct DNA strand breaks in NIH-3T3 and Ehrlich ascites carcinoma (EAC) cells. Cheng et al (43) demonstrated the capability of BBR to photosensitize DNA cleavage, and demonstrated that electron transfer via BBR neutral radicals to guanine neutral radicals plays an important role in DNA cleavage, and that both single- and double-stranded DNA at guanine moieties can be selectively cleaved by photoexcited BBR. The results of this study also clarified the molecular mechanisms of BBR-induced photodamage of dGMP and DNA.

DNA binding enhances the lifespan of photoexcited BBR states and generates 1O2; meanwhile, it is destroyed in the process (31,38). Understanding and utilizing this interaction and antinomy may provide insight to photosensitizer design based on BBR and its biological applications.

Photochemical functional groups of BBR

The functional groups of BBR are important for its photochemical properties (27,44,45). The structures of BBR derivatives are summarized in Fig. 3. Brezová et al (27) compared the photoexcited oxygen activation of BBR and its derivatives, palmatine and jatrorrhizine. The methylenedioxy group at the C-2 and C-3 positions of BBR is photolabile (27). When these groups are replaced by two methoxy groups (palmatine) or C-2 methoxyl and C-3 hydroxyl (jatrorrhizine), the photochemical generation of O2•− and 1O2 significantly decreases in DMSO solution (27). The UV/Vis absorption in regions of 350 and 425 nm in DMSO and EtOH is also influenced by the substitutional changes (27). However, DNA binding and associated photochemical reactions have failed to demonstrate differences between BBR and palmatine (38,40,41). In addition, the effects of solvent polarity on the photoirradiation reactions of BBR and palmatine are similar (37). The antitumor effects of palmatine mediated PDT were proven in vitro using several cancer cell lines, such as MCF-7 and HT-29 cells (44,46,47).

Coralyne, a protoberberine alkaloid (45), has a C-7 methyl group replace based on palmatine, which has been demonstrated to cause robust photosensitization of cancer cells (45). The ΦΔ of coralyne is independent of solvent polarity unlike BBR and palmatine (37). Patro et al (48) reported that coralyne induces significant nicking of plasmid DNA via an O2-independent photochemical process; however, the phenomenon has not been observed in BBR or jatrorrhizine. Ihmels and Salbach (49) demonstrated that coralyne irradiation results in significant DNA damage. The extent of the damage does not differ between aerobic and anaerobic conditions; however, the extent of the damage is significantly different to that induced by BBR.

Basu et al (50,51) synthesized BBR analogs with substituents at the 9-O-position of the isoquinoline chromophore and demonstrated that these analogs enhance the binding affinities of BBR to both DNA and double stranded poly(A). Liu et al (52) confirmed increased DNA binding of several 9-O-substituted BBR derivatives, and one of the derivatives exhibited higher cytotoxicity in HL-60 and BGC-823 cells compared with BBR. Since the photochemical functional groups were not altered, and DNA binding has significant influence on the ΦΔ of BBR, such substitutions may enhance the photochemical properties of BBR; however, further experimental verification is required. Arnason et al (25) determined the ΦΔ of sanguinarine, which was demonstrated to be lower than BBR (0.16 vs. 0.25). The median lethal dose of sanguinarine to mosquito larvae significantly decreased from 23.3 mg/ml to 0.096 mg/ml following near-UV exposure. Görner et al (36) confirmed that the absorption spectra of sanguinarine is altered upon change in pH in a 9:1 mixture of MeOH and water, whereby the main product upon irradiation at 313 nm is 6-oxysanguinarine. The ΦΔ of sanguinarine is lower than BBR in several solvents (37), suggesting that the methylenedioxy group of C-9 and C-10 is not beneficial to photoactivity.

Taken together, these results suggest that changing the substituents of photochemical functional groups of BBR affect its photochemical properties, which provides insight for the molecular design of a BBR-based photosensitizer.

Biological effects of BBR-mediated PDT

Since the discovery of the photochemical properties of BBR, the applications of BBR- mediated PDT in biology have attracted great attention.

Application of BBR-mediated-PDT in non-neoplastic diseases

BBR-PDT has been proven to treat a variety of non-neoplastic diseases. Philogène et al (13) demonstrated the phototoxicity of BBR to mosquito larvae, whereby the median lethal concentration decreased from 250 to 8.8 ppm in the presence of near UV. Molero et al (53) reported that the growth of Allium cepa Linn. var. cepa roots is inhibited by BBR upon irradiation of violet light (420 nm). Inbaraj et al (26) determined the phototoxicity of BBR to HaCaT keratinocytes and demonstrated that 50 µM BBR combined with UVA irradiation decreases the cell viability to 20%, and the DNA damage exhibited a 3-fold increase compared with UVA alone. BBR is an efficient fluorescent probe, and BBR-PDT has demonstrated potent bactericidal effects, both in vivo and in vitro (54). Lee et al (55) reported that BBR successfully stains the Gram-positive bacteria, Staphylococcus aureus (S. aureus), whereas it only partly stains the Gram-negative Escherichia coli (E. coli). BBR-PDT significantly decreases the viability of S. aureus, and the bactericidal effects occur in a dose-dependent manner (5–10 mM BBR). BBR-PDT also exhibits bactericidal effects in E. coli; however, the efficiency is lower and the required concentration of BBR is higher (55).

Antitumor effects of BBR-mediated PDT

Recently, the antitumor effects of BBR-PDT have attracted great interest. The activity in vitro was first demonstrated by Wang in 1986 (14), who observed the strong inhibitory proliferation of SGC-803 gastric cancer cells combined with BBR (10 µg/ml) under illumination, using a black light lamp (320–450 nm; 20 W). Ma et al (56) demonstrated that BBR combined with 5-ALA-PDT significantly inhibits the proliferation of MGC-803 gastric cancer cells, induces cell apoptosis, inhibits the expression levels of survivin and Bcl-2, and upregulates the expression levels of p53 and Bax. Taken together, these results suggest that BBR has the potential to be used in combination with other photosensitizers. Chen et al (57) studied the effects of BBR in combination with argon ion lasers on 9L rat glioma cells, and demonstrated that the argon ion laser enhances the inhibition of BBR on DNA, RNA and protein biosynthesis, resulting in cell-killing effects. Jantová et al (31) compared the cytotoxic and phototoxic effects on murine fibroblast NIH-3T3 and EAC cells. The results demonstrated that EAC cells are more sensitive to photoactivated BBR compared with non-cancer NIH-3T3 cells. BBR-PDT induces the DNA damage of EAC cells, subsequently blocking the S and G2/M phases, and decreases cell proliferation. In addition, DNA damage induces necrotic or apoptotic death of EAC cells (31). Lopes et al (58) demonstrated that BBR cytotoxicity increases by 20% following the combination of light. ROS production and activation of autophagy and apoptosis induced by BBR-PDT are responsible for the death of renal carcinoma cells. In addition, BBR-PDT affects the expression of anticancer drug target genes in 786-O cells (58). Warowicka et al (59) investigated the potential anticancer effects of a protoberberine alkaloidal fraction on HeLa and C33A cervical cancer cells. Liu et al (15) verified the antitumor effects of BBR-PDT in xenograft animal models, and revealed the role of the PI3K/AKT/mTOR signaling pathway.

The biological effects of BBR-PDT are summarized in Fig. 4. Among these, the mechanisms of BBR-PDT in treating tumors may involve inhibiting cell proliferation, inducing apoptosis and autophagy, and altering the expression of proteins or genes (15). However, there are a few studies currently investigating these mechanisms. BBR exhibits clear inhibitory effects on different types of cancer, including colorectal, lung, ovarian, prostate, liver and cervical cancers (60). This suggests that BBR-PDT may have more potent antitumor effects compared with other photosensitizers due to the superposition of the antitumor effects of BBR and PDT (15,61). However, only a few studies have proven the antitumor effects of BBR-PDT (15,31,59). The possible reasons are as follows (16): i) There are multiple factors influencing the photodynamic reactions of BBR; ii) the hydrophobic properties, along with poor stability and bioavailability of BBR limits its application; iii) BBR has high toxicity, particularly when administered by injection; and iv) the light source of BBR-PDT is UV, which has several side effects. such as burn and pain and no advantages compared with other photosensitizers (2).

BBR-mediated SDT

SDT is a promising new option for the invasive treatment of tumors (62). SDT is similar to PDT in that it requires the combination of sensitizers, ultrasound and molecular oxygen (61). The major advantage of SDT compared with PDT is the increased penetration of ultrasound through mammalian tissues compared with light, indicating that it can be used to treat deeper and less accessible tumors (61,62). As the light source of BBR-PDT is UV, which has several side effects, such as burn and pain, BBR-SDT may be a more favorable choice for treating tumors (16). Wang et al (63) reported that BBR can enhance ultrasound-induced BSA molecule damage. The increase in the degree of damage is accompanied with the increase of BBR concentration and ultrasonic irradiation time. It was further revealed that BBR-SDT-mediated BSA damage is mediated by the production of ROS, particularly 1O2 (63).

Atherosclerosis (AS) is the major contributing factor of cardiovascular events. SDT-targeting AS is considered a novel promising treatment strategy for AS (64). Tian and Guo (65) investigated the effects of BBR-SDT on macrophages within atherosclerotic plaques. Kou et al (66) demonstrated that BBR-SDT induces autophagy and cholesterol efflux in THP-1 macrophages and derived foam cells, which may potentially involve inhibiting phosphorylation of the PI3K/AKT/mTOR signaling pathway. In addition, the effects of BBR-mediated SDT on macrophages within atherosclerotic plaques were investigated.

Only a few studies have reported the antitumor effects of BBR-SDT. For example, Liu et al (16) demonstrated that BBR-SDT inhibits the proliferation of HeLa cells and induces apoptosis both in vitro and in vivo, and revealed the role of the PI3K/AKT/mTOR signaling pathway in this process. However, further studies are required to validate the antitumor effects of BBR-SDT. SDT has several advantages over PDT due to its deeper penetration and fewer side effects (64). However, the chemical properties of BBR, such as its hydrophobic properties, poor stability and bioavailability, and high toxicity need to be resolved (16).

Targeted delivery for BBR

The question remains as to how to overcome the physical shortcomings of BBR. Feasible options include chemical structure modification and targeted drug delivery (51,67). The photochemical properties of BBR are associated with the substituents at the C-2, C-3, C-7 and 9-O positions (27,45,50). Appropriate chemical structure modifications may increase its water solubility and retain or even improve its photodynamic activity; however, this requires experimental verification (68). In addition, targeted delivery may also avoid the dissolution and low absorption of BBR (6973).

Several nanoparticulate delivery systems have been used to target the delivery of BBR. For example, Sun and Ouyang (67) prepared BBR hydrochloride, a nanoemulsion, which is a clear transparent solution with stable contents and diameter, even under high humidity and high temperatures. As a stable drug delivery system, BBR nanoemulsion has a high affinity for gastrointestinal lymphatic tissue. It can deliver larger amounts of BBR into the blood via the lymphatic system, avoid the biotransformation and absorption of the liver and intestines, and exhibit a first pass effect in the liver (67). Solid lipid nanoparticles can effectively control drug release, avoid drug degradation or leakage, and have potent targeting properties (74). Hou and Zhou (75) prepared solid lipid nanoparticles of BBR hydrochlorideusing a rotary-evaporated film-ultrasonication method. In addition, Wang et al (76) determined its entrapment efficiency.

Liposomes have similar structures to cell membranes and high affinities to tissues or cells (77). There are several approaches for the preparation of BBR liposomes, such as thin film evaporation and active loading (78). Incubation temperature and duration, the proportional weight of drugs and lipids, soybean phosphatidylcholine and cholesterol affect the encapsulation rate (79). Luo et al (78) prepared a long-circulating liposome of BBR hydrochloride using an ionophore A23187-mediated ZnSO4 gradient method. Using poly (lactic-co-glycolic acid) (PLGA) nanoparticles is a new strategy to promote specific targeting and elimination of drugs (80). Khan et al (81) developed a co-delivery system of BBR and doxorubicin using the conjugation/encapsulation strategy through PLGA nanoparticles. Co-delivery of BBR and other anticancer drugs is valuable to achieve higher anticancer effectivity (82). Guo et al (83) designed a liver-target nanotechnology system to facilitate BBR consisting of α-tocopheryl hydrophobic core and on-site detachable polyethylene glycol-thiol shell to improve its liver deposition.

Cellular and molecular targeting can further enhance the effects of BBR and decrease its adverse reactions. Bhatnagar et al (84) prepared BBR chloride (BRB)-encapsulated hyaluronic acid-grafted [d(HA)-g]-PLGA nanoparticles (NPs). The BRB-d(HA)-g-PLGA NPs were used to target CD44-positive cancer cells. These NPs released BRB at a faster rate in HeLa and MCF-7 cells compared with BRB-PLGA NPs and bulk BRB, and increased its cytotoxicity. These results offer a promising and improved alternative for antitumor therapy. Song et al (68) obtained a novel mitochondria-targeting nanodrug self-assembled BBR derivative from a 9-O-octadecyl substitute using a simple nano-precipitation approach. These authors further used 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethyleneglycol) 2000] to modify the BBR derivative to increase its stability. Negatively charged HA was further coated to conceal positive charges and achieve tumor targeting. Grebinyk et al (85) formed a nanocomplex combining C60 fullerene and BBR, and C60 was demonstrated to promote BBR intracellular uptake by leukemic cells.

Collectively, these targeted delivery strategies provide solutions to the limitations of BBR, such as its hydrophobic properties, poor stability and bioavailability. Cellular and molecular targeted delivery allows the possibility of further improving its therapeutic effects. However, there is currently no evidence regarding the use of these BBR delivery systems in PDT or SDT, which is worth investigating in prospective studies. In addition, the toxicity of BBR should be concerned in future applications with targeted delivery technology, particularly for free BBR, which may produce systemic adverse reactions.

Conclusions and prospects

BBR is a photosensitizer that can be activated by both light and ultrasound, and produce 1O2. Both type I and type II reactions participate in the photochemical reactions of BBR. However, BBR reactions under ultrasound irradiation remain unclear. Both BBR-PDT and BBR-SDT have been proven to inhibit the proliferation and induce the apoptosis of several tumor cell lines in vitro. However, only a few studies have been validated in animal models, and the antitumor activities in vivo require further confirmation. Notably, both BBR-PDT and BBR-SDT can induce autophagy, which may be associated with the phosphorylation inhibition of the PI3K/AKT/mTOR signaling pathway. Although autophagy is generally considered to exert protective effects on cells, its role in the biological effects of BBR-PDT and BBR-SDT remain to be elucidated, particularly their antitumor effects. In addition, only a few proteins and genes involved in apoptosis have been identified to be regulated by BBR-PDT or BBR-SDT. Thus, it is important to clarify the antitumor mechanisms of BBR-PDT and BBR-SDT in prospective studies.

The photothermic characteristics of BBR are affected by polarity, pH and O2 content of solvents. Its hydrophobic properties, along with poor stability and bioavailability, and the high toxicity of BBR limits its application. It is also unclear whether the interactions between BBR and DNA is beneficial for PDT. Appropriate structural modifications at the C-2, C-3, C-7 and 9-O positions may change the water solubility and photodynamic efficiency of BBR; however, whether this is advantageous to BBR-PDT requires experimental verification. Targeting drug delivery via microbubbles may bypass the physical and chemical defects of BBR and enhance its antitumor effects via PDT and SDT. However, it is worth noting that BBR is highly toxic following intravenous injection. Although targeted delivery can theoretically only sequester BBR in the target tissues, the safety requires verification, particularly with regards to systemic toxicity.

In conclusion, BBR has a developmental prospect as a sensitizer for PDT and SDT treatment. Its simple structure, low cost and extensive pharmacological activities, such as antitumor effect, exhibit great advantage over other photosensitizers. Thus, the present study hypothesizes that BBR-PDT and BBR-SDT will be extensively used in clinical treatment in the future.

Acknowledgements

Not applicable.

Funding

The present review was supported by the Shenzhen Science and Technology Planning Project (grant nos. JCYJ20180302153611416 and JYCJ20190808160011529) and the Research Foundation of Shenzhen Samii Medical Center.

Availability of data and materials

Not applicable.

Authors' contributions

YWA and HQL drafted the initial manuscript. YWA, HTJ and HQL confirmed the authenticity of all the raw data. HTJ, BY, JCW and CW performed the literature review and produced Figs. 1 and 4. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Glossary

Abbreviations

Abbreviations:

BBR

berberine

3BBR*

triple excited state of BBR

BBR•+

BBR radical cation

PDT

photodynamic therapy

SDT

sonodynamic therapy

ROS

reactive oxygen species

1O2

singlet oxygen

O2•−

superoxide radical anion

OH

hydroxyl radicals

DMF

2,5-dimethyl furan

CH2Cl2

dichloromethane

EPR

electron paramagnetic resonance

D2O

aqueous

MeOH

methanol

DMSO

oxygenated dimethyl sulfoxide

Lys

lysozyme

EtOH

ethanol

EAC

ehrlich ascites carcinoma

PLGA

poly (lactic-co-glycolic acid)

NPs

nanoparticles

References

1 

Rkein AM and Ozog DM: Photodynamic therapy. Dermatol Clin. 32:415–425. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Chilakamarthi U and Giribabu L: Photodynamic therapy: Past, present and future. Chem Rec. 17:775–802. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Moy LS, Frost D and Moy S: Photodynamic therapy for photodamage, actinic keratosis, and acne in the cosmetic practice. Facial Plast Surg Clin North Am. 28:135–148. 2020. View Article : Google Scholar : PubMed/NCBI

4 

Ghorbani J, Rahban D, Aghamiri S, Teymouri A and Bahador A: Photosensitizers in antibacterial photodynamic therapy: An overview. Laser Ther. 27:293–302. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Zhang J, Jiang C, Figueiró Longo JP, Azevedo RB, Zhang H and Muehlmann LA: An updated overview on the development of new photosensitizers for anticancer photodynamic therapy. Acta Pharm Sin B. 8:137–146. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Abrahamse H and Hamblin MR: New photosensitizers for photodynamic therapy. Biochem J. 473:347–364. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Kataoka H, Nishie H, Hayashi N, Tanaka M, Nomoto A, Yano S and Joh T: New photodynamic therapy with next-generation photosensitizers. Ann Transl Med. 5:1832017. View Article : Google Scholar : PubMed/NCBI

8 

Mansoori B, Mohammadi A, Amin Doustvandi M, Mohammadnejad F, Kamari F, Gjerstorff MF, Baradaran B and Hamblin MR: Photodynamic therapy for cancer: Role of natural products. Photodiagnosis Photodyn Ther. 26:395–404. 2019. View Article : Google Scholar : PubMed/NCBI

9 

Ortiz LM, Lombardi P, Tillhon M and Scovassi AI: Berberine, an epiphany against cancer. Molecules. 19:12349–12367. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Neag MA, Mocan A, Echeverria J, Pop RM, Bocsan CI, Crişan G and Buzoianu AD: Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 9:5572018. View Article : Google Scholar : PubMed/NCBI

11 

Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, Šmejkal K, Malaník M, et al: Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics. 9:1923–1951. 2019. View Article : Google Scholar : PubMed/NCBI

12 

Liu D, Meng X, Wu D, Qiu Z and Luo H: A natural isoquinoline alkaloid with antitumor activity: Studies of the biological activities of berberine. Front Pharmacol. 10:92019. View Article : Google Scholar : PubMed/NCBI

13 

Philogène BJ, Arnason JT, Towers GH, Abramowski Z, Campos F, Champagne D and McLachlan D: Berberine: A naturally occurring phototoxic alkaloid. J Chem Ecol. 10:115–123. 1984. View Article : Google Scholar : PubMed/NCBI

14 

Wang MX, Huo LM, Yang HC, Gao YJ and E Z: An experimental study on the photodynamic activity of berberine in vitro on cancer cells. J Tradit Chin Med. 6:125–127. 1986.PubMed/NCBI

15 

Liu HQ, An YW, Hu AZ, Li MH and Cui GH: Photodynamic therapy enhanced the antitumor effects of berberine on HeLa cells. Open Chemistry. 17:413–421. 2019. View Article : Google Scholar

16 

Liu H, Zheng T, Zhou Z, Hu A, Li M, Zhang Z, Yu G, Feng H, An Y, Peng J and Chen Y: Berberine nanoparticles for promising sonodynamic therapy of a HeLa xenograft tumour. Rsc Advances. 9:10528–10535. 2019. View Article : Google Scholar

17 

Acamovic T and Brooker JD: Biochemistry of plant secondary metabolites and their effects in animals. Proc Nutr Soc. 64:403–412. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Schreiner M, Mewis I, Huyskens-Keil S, Jansen MAK, Zrenner R, Winkler JB, O'Brien N and Krumbein A: UV-B-induced secondary plant metabolites-potential benefits for plant and human health. Crit Rev Plant Sci. 31:229–240. 2012. View Article : Google Scholar

19 

Gismondi A, Marco GD, Canuti L and Canini A: Antiradical activity of phenolic metabolites extracted from grapes of white and red Vitis vinifera L. cultivars. Vitis J Grapevine Res. 56:19–26. 2017.

20 

Makkar HPS, Siddhuraju P and Becker K: Plant Secondary Metabolites. Humana Press; Totowa, NJ, USA: 2007, View Article : Google Scholar

21 

Lockwood B: Plant Secondary Metabolites Occurrence, Structure and Role in the Human Diet. Crozier A, Clifford MN and Ashihara H: Blackwell Publishing Ltd; pp. 384GBP 99.50, ISBN 13: 978-1-4051-2509-3. Phytochemistry. 69. pp. 1288. 2008, View Article : Google Scholar

22 

Steglich W: Plant Secondary Metabolites. Occurrence, Structure and Role in the Human Diet. Alan Crozier, Clifford MN and Ashihara H: Angewandte Chemie International Edition. 46. pp. 8113–8114. 2007, View Article : Google Scholar

23 

Crozier A, Clifford MN and Ashihara H: Plant Secondary Metabolites: Occurrence Structure and Role in the Human Diet. Blackwell Publishing Ltd; UK: 2006

24 

Agarwal R, Zaidi SI, Athar M, Bickers DR and Mukhtar H: Photodynamic effects of chloroaluminum phthalocyanine tetrasulfonate are mediated by singlet oxygen: In vivo and in vitro studies utilizing hepatic microsomes as a model membrane source. Arch Biochem Biophys. 294:30–37. 1992. View Article : Google Scholar : PubMed/NCBI

25 

Arnason JT, Guerin B, Kraml MM, Mehta B, Redmond RW and Scaiano JC: Phototoxic and photochemical properties of sanguinarine. Photochem Photobiol. 55:35–38. 1992. View Article : Google Scholar : PubMed/NCBI

26 

Inbaraj JJ, Kukielczak BM, Bilski P, Sandvik SL and Chignell CF: Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.) 1. Berberine. Chem Res Toxicol. 14:1529–1534. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Brezová V, Dvoranova D and Kost'alova D: Oxygen activation by photoexcited protoberberinium alkaloids from Mahonia aquifolium. Phytother Res. 18:640–646. 2004. View Article : Google Scholar : PubMed/NCBI

28 

Cheng LL, Wang M, Zhu H, Li K, Zhu RR, Sun XY, Yao SD, Wu QS and Wang SL: Characterization of the transient species generated by the photoionization of Berberine: A laser flash photolysis study. Spectrochim Acta A Mol Biomol Spectrosc. 73:955–959. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Hackbarth S, Islam W, Fang J, Šubr V, Röder B, Etrych T and Maeda H: Singlet oxygen phosphorescence detection in vivo identifies PDT-induced anoxia in solid tumors. Photochem Photobiol Sci. 18:1304–1314. 2019. View Article : Google Scholar : PubMed/NCBI

30 

Dmitrieva VA, Tyutereva EV and Voitsekhovskaja OV: Singlet oxygen in plants: Generation, detection, and signaling roles. Int J Mol Sci. 21:32372020. View Article : Google Scholar

31 

Jantová S, Letasiova S, Brezova V, Cipak L and Labaj J: Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells. J Photochem Photobiol B. 85:163–176. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Cheng L, Wang M, Zhao P, Zhu H, Zhu R, Sun X, Yao S and Wang S: The examination of berberine excited state by laser flash photolysis. Spectrochim Acta A Mol Biomol Spectrosc. 73:268–272. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Cheng LL, Wang M, Wu MH, Yao SD, Jiao Z and Wang SL: Interaction mechanism between berberine and the enzyme lysozyme. Spectrochim Acta A Mol Biomol Spectrosc. 97:209–214. 2012. View Article : Google Scholar : PubMed/NCBI

34 

Shen L and Ji HF: The mechanisms of ROS-photogeneration by berberine, a natural isoquinoline alkaloid. J Photochem Photobiol B. 99:154–156. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Liu R and Zhang Y: Mechanism of UV-driven photoelectrocatalytic degradation of berberine chloride form using the ESR Spin-trapping method. Photochem Photobiol. 94:650–658. 2018. View Article : Google Scholar : PubMed/NCBI

36 

Görner H, Miskolczy Z, Megyesi M and Biczok L: Photooxidation of alkaloids: Considerable quantum yield enhancement by rose bengal-sensitized singlet molecular oxygen generation. Photochem Photobiol. 87:1315–1320. 2011. View Article : Google Scholar : PubMed/NCBI

37 

Görner H, Miskolczy Z, Megyesi M and Biczok L: Photoreduction and ketone-sensitized reduction of alkaloids. Photochem Photobiol. 87:284–291. 2011. View Article : Google Scholar : PubMed/NCBI

38 

Hirakawa K, Kawanishi S and Hirano T: The mechanism of guanine specific photooxidation in the presence of berberine and palmatine: Activation of photosensitized singlet oxygen generation through DNA-binding interaction. Chem Res Toxicol. 18:1545–1552. 2005. View Article : Google Scholar : PubMed/NCBI

39 

Chen XW, Di YM, Zhang J, Zhou ZW, Li CG and Zhou SF: Interaction of herbal compounds with biological targets: A case study with berberine. ScientificWorldJournal. 2012:7082922012. View Article : Google Scholar : PubMed/NCBI

40 

Hirakawa K and Hirano T: The microenvironment of DNA switches the activity of singlet oxygen generation photosensitized by berberine and palmatine. Photochem Photobiol. 84:202–208. 2008.PubMed/NCBI

41 

Hirakawa K, Hirano T, Nishimura Y, Arai T and Nosaka Y: Dynamics of singlet oxygen generation by DNA-binding photosensitizers. J Phys Chem B. 116:3037–3044. 2012. View Article : Google Scholar : PubMed/NCBI

42 

Jiang D and Rusling JF: Oxidation chemistry of DNA and p53 tumor suppressor gene. ChemistryOpen. 8:252–265. 2019. View Article : Google Scholar : PubMed/NCBI

43 

Cheng LL, Wang YJ, Huang DH, Yao SD, Ding GJ, Wang SL and Jiao Z: Radiolysis and photolysis studies on active transient species of berberine. Spectrochim Acta A Mol Biomol Spectrosc. 124:670–676. 2014. View Article : Google Scholar : PubMed/NCBI

44 

Wu J, Xiao Q, Zhang N, Xue C, Leung AW, Zhang H, Tang QJ and Xu C: Palmatine hydrochloride mediated photodynamic inactivation of breast cancer MCF-7 cells: Effectiveness and mechanism of action. Photodiagnosis Photodyn Ther. 15:133–138. 2016. View Article : Google Scholar : PubMed/NCBI

45 

Bhattacharyya R, Gupta P, Bandyopadhyay SK, Patro BS and Chattopadhyay S: Coralyne, a protoberberine alkaloid, causes robust photosenstization of cancer cells through ATR-p38 MAPK-BAX and JAK2-STAT1-BAX pathways. Chem Biol Interact. 285:27–39. 2018. View Article : Google Scholar : PubMed/NCBI

46 

Wu J, Xiao Q, Zhang N, Xue C, Leung AW, Zhang H, Xu C and Tang QJ: Photodynamic action of palmatine hydrochloride on colon adenocarcinoma HT-29 cells. Photodiagnosis Photodyn Ther. 15:53–58. 2016. View Article : Google Scholar : PubMed/NCBI

47 

Qi F, Sun Y, Lv M, Qin F, Cao W and Bi L: Effects of palmatine hydrochloride mediated photodynamic therapy on oral squamous cell carcinoma. Photochem Photobiol Sci. 18:1596–1605. 2019. View Article : Google Scholar : PubMed/NCBI

48 

Patro BS, Bhattacharyya R, Gupta P, Bandyopadhyay S and Chattopadhyay S: Mechanism of coralyne-mediated DNA photo-nicking process. J Photochem Photobiol B. 194:140–148. 2019. View Article : Google Scholar : PubMed/NCBI

49 

Ihmels H and Salbach A: Efficient photoinduced DNA damage by coralyne. Photochem Photobiol. 82:1572–1576. 2006. View Article : Google Scholar : PubMed/NCBI

50 

Basu A, Jaisankar P and Kumar GS: Photophysical and calorimetric studies on the binding of 9-O-substituted analogs of the plant alkaloid berberine to double stranded poly(A). J Photochem Photobiol B. 125:105–114. 2013. View Article : Google Scholar : PubMed/NCBI

51 

Basu A, Jaisankar P and Suresh Kumar G: Synthesis of novel 9-O-N-aryl/aryl-alkyl amino carbonyl methyl substituted berberine analogs and evaluation of DNA binding aspects. Bioorg Med Chem. 20:2498–2505. 2012. View Article : Google Scholar : PubMed/NCBI

52 

Liu C, Liu S, Wang Y, Wang S, Zhang J, Li S, Qin X, Li X, Wang K and Zhou Q: Synthesis, cytotoxicity, and DNA-binding property of berberine derivatives. Med Chemistry Res. 23:1899–1907. 2014. View Article : Google Scholar

53 

Molero ML, Hazen MJ and Stockert JC: Photodynamic effect of berberine sulfate on the growth rate of allium cepa roots. J Plant Physiol. 120:91–94. 1985. View Article : Google Scholar

54 

Lee NK, Jenner L, Harney A and Cameron J: Pharmacotherapy for amphetamine dependence: A systematic review. Drug Alcohol Depend. 191:309–337. 2018. View Article : Google Scholar : PubMed/NCBI

55 

Lee MMS, Zheng L, Yu B, Xu W, Kwok RTK, Lam JWY, Xu F, Wang D and Tang BZ: A highly efficient and AIE-active theranostic agent from natural herbs. Materials Chemistry Front. 3:1454–1461. 2019. View Article : Google Scholar

56 

Ma XQ, Liu HL, Cheng GP, Yuan SC and Liang B: Effects of berberine combined with photodynamic on apoptosis of gastric cancer MGC-803 Cell. Chin J Clin Pharmacol Therapeutics. 20:961–966. 2015.

57 

Chen KT, Hao DM, Liu ZX, Chen YC and You ZS: Effect of berberine alone or in combination with argon ion laser treatment on 9L rat glioma cell line. Chin Med J (Engl). 107:808–812. 1994.PubMed/NCBI

58 

Lopes TZ, de Moraes FR, Tedesco AC, Arni RK, Rahal P and Calmon MF: Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells. Biomed Pharmacother. 123:1097942020. View Article : Google Scholar : PubMed/NCBI

59 

Warowicka A, Popenda Ł, Bartkowiak G, Musidlak O, Litowczenko-Cybulska J, Kuźma D, Nawrot R, Jurga S and Goździcka-Józefiak A: Protoberberine compounds extracted from Chelidonium majus L. as novel natural photosensitizers for cancer therapy. Phytomedicine. 64:1529192019. View Article : Google Scholar : PubMed/NCBI

60 

Wang Y, Liu Y, Du X, Ma H and Yao J: The anti-cancer mechanisms of berberine: A review. Cancer Manag Res. 12:695–702. 2020. View Article : Google Scholar : PubMed/NCBI

61 

Liu HQ, An YW, Li ZW, Li WX, Yuan B, Wang JC, Jin HT and Wang C: Sinoporphyrin sodium, a novel sensitizer for photodynamic and sonodynamic therapy. Open Chemistry. 18:691–701. 2020. View Article : Google Scholar

62 

An YW, Liu HQ, Zhou ZQ, Wang JC, Jiang GY, Li ZW, Wang F and Jin HT: Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma. Oncol Rep. 44:1596–1604. 2020.PubMed/NCBI

63 

Wang X, He L, Liu B and Wang J: Spectroscopic investigation on the sonodynamic damage to proteins in the presence of berberine in vitro. J Luminescence. 131:1361–1367. 2011. View Article : Google Scholar

64 

Geng C, Zhang Y, Hidru TH, Zhi L, Tao M, Zou L, Chen C, Li H and Liu Y: Sonodynamic therapy: A potential treatment for atherosclerosis. Life Sci. 207:304–313. 2018. View Article : Google Scholar : PubMed/NCBI

65 

Tian Y and Guo S: Sonodynamic effect of berberine on macrophages. Heart. 98:E87–E88. 2012.

66 

Kou JY, Li Y, Zhong ZY, Jiang YQ, Li XS, Han XB, Liu ZN, Tian Y and Yang LM: Berberine-sonodynamic therapy induces autophagy and lipid unloading in macrophage. Cell Death Dis. 8:e25582017. View Article : Google Scholar : PubMed/NCBI

67 

Sun HW and Ouyang WQ: Preparation and physicochemical characteristics of berberine hydrochloric nanoemulsion. Chin Traditional Herbal Drugs. 38:1476–1480. 2007.

68 

Song J, Lin C, Yang X, Xie Y, Hu P, Li H, Zhu W and Hu H: Mitochondrial targeting nanodrugs self-assembled from 9-O-octadecyl substituted berberine derivative for cancer treatment by inducing mitochondrial apoptosis pathways. J Control Release. 294:27–42. 2019. View Article : Google Scholar : PubMed/NCBI

69 

Fan JX, Liu MD, Li CX, Hong S, Zheng DW, Liu XH, Chen S, Cheng H and Zhang XZ: A metal-semiconductor nanocomposite as an efficient oxygen-independent photosensitizer for photodynamic tumor therapy. Nanoscale Horiz. 2:349–355. 2017. View Article : Google Scholar : PubMed/NCBI

70 

Wang C, Dai C, Hu Z, Li H, Yu L, Lin H, Bai J and Chen Y: Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms. Nanoscale Horiz. 4:415–425. 2019. View Article : Google Scholar : PubMed/NCBI

71 

Zhen W, Liu Y, Jia X, Wu L, Wang C and Jiang X: Reductive surfactant-assisted one-step fabrication of a BiOI/BiOIO3 heterojunction biophotocatalyst for enhanced photodynamic theranostics overcoming tumor hypoxia. Nanoscale Horiz. 4:720–726. 2019. View Article : Google Scholar

72 

Zhang D, Zhang J, Li Q, Tian H, Zhang N, Li Z and Luan Y: pH- and enzyme-sensitive IR820-paclitaxel conjugate self-assembled nanovehicles for near-infrared fluorescence imaging-guided chemo-photothermal therapy. ACS Appl Mater Interfaces. 10:30092–30102. 2018. View Article : Google Scholar : PubMed/NCBI

73 

Zhang J, Zhang D, Li Q, Jiang Y, Song A, Li Z and Luan Y: Task-specific design of immune-augmented nanoplatform to enable high-efficiency tumor immunotherapy. ACS Appl Mater Interfaces. 11:42904–42916. 2019. View Article : Google Scholar : PubMed/NCBI

74 

Rajpoot K: Solid lipid nanoparticles: A promising nanomaterial in drug delivery. Curr Pharm Des. 25:3943–3959. 2019. View Article : Google Scholar : PubMed/NCBI

75 

Hou J and Zhou SW: Optimization of the preparation technology of berberine hydrochloride solid lipid nanoparticles by orthogonal experiment. China Pharmacy. 19:1150–1152. 2008.

76 

Wang Y, Zheng J, Xu B, Wang H, Deng Y and Bi D: Determination of entrapment efficiency of berberine hydrochloride solid lipid nanoparticles by coagulation-centrifuge method. J Zhengzhou Univ (Med Ences). 44:188–189. 2009.

77 

Elhissi A: Liposomes for pulmonary drug delivery: The role of formulation and inhalation device design. Curr Pharm Des. 23:362–372. 2017. View Article : Google Scholar : PubMed/NCBI

78 

Luo X, Li J, Guo L, Cheng X, Zhang T and Deng Y: Preparation of berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO4 gradient method. Asian J Pharmaceutical Ences. 8:261–266. 2013. View Article : Google Scholar

79 

Chen J, Tian L, Li W and Li G: Study on the preparation process of berberine hydrochloride liposomes by orthogonal design. J Practical Med Techniques. 14:1868–1870. 2007.

80 

Kapoor DN, Bhatia A, Kaur R, Sharma R, Kaur G and Dhawan S: PLGA: A unique polymer for drug delivery. Ther Deliv. 6:41–58. 2015. View Article : Google Scholar : PubMed/NCBI

81 

Khan I, Joshi G, Nakhate KT, Ajazuddin, Kumar R and Gupta U: Nano-Co-delivery of berberine and anticancer drug using PLGA nanoparticles: Exploration of better anticancer activity and in vivo kinetics. Pharm Res. 36:1492019. View Article : Google Scholar : PubMed/NCBI

82 

Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X and Lu Z: Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5:811–818. 2020. View Article : Google Scholar : PubMed/NCBI

83 

Guo HH, Feng CL, Zhang WX, Luo ZG, Zhang HJ, Zhang TT, Ma C, Zhan Y, Li R, Wu S, et al: Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases. Nat Commun. 10:19812019. View Article : Google Scholar : PubMed/NCBI

84 

Bhatnagar P, Kumari M, Pahuja R, Pant AB, Shukla Y, Kumar P and Gupta KC: Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Drug Deliv Transl Res. 8:565–579. 2018. View Article : Google Scholar : PubMed/NCBI

85 

Grebinyk A, Prylutska S, Buchelnikov A, Tverdokhleb N, Grebinyk S, Evstigneev M, Matyshevska O, Cherepanov V, Prylutskyy Y, Yashchuk V, et al: C60 fullerene as an effective nanoplatform of alkaloid berberine delivery into leukemic cells. Pharmaceutics. 11:5862019. View Article : Google Scholar

Related Articles

Journal Cover

May-2021
Volume 21 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
An Y, Jin H, Yuan B, Wang J, Wang C and Liu H: Research progress of berberine mediated photodynamic therapy (Review). Oncol Lett 21: 359, 2021.
APA
An, Y., Jin, H., Yuan, B., Wang, J., Wang, C., & Liu, H. (2021). Research progress of berberine mediated photodynamic therapy (Review). Oncology Letters, 21, 359. https://doi.org/10.3892/ol.2021.12620
MLA
An, Y., Jin, H., Yuan, B., Wang, J., Wang, C., Liu, H."Research progress of berberine mediated photodynamic therapy (Review)". Oncology Letters 21.5 (2021): 359.
Chicago
An, Y., Jin, H., Yuan, B., Wang, J., Wang, C., Liu, H."Research progress of berberine mediated photodynamic therapy (Review)". Oncology Letters 21, no. 5 (2021): 359. https://doi.org/10.3892/ol.2021.12620